Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart

Weina Chen, William Wetsel, Charles Jr Steenbergen, Elizabeth Murphy

Research output: Contribution to journalArticle

Abstract

Ischemic preconditioning (PC) has been shown to attenuate intracellular acidification during a subsequent period of ischemia, to minimize stunning, and to decrease infarct size, PKC activation has been suggested to be involved in this phenomenon, The present study is designed to test whether PKC activation could mimic and PKC inhibition could block the PC effects on intracellular acidification during ischemia and on stunning during reflow in Langendorff perfused rat hearts. Prior to 20 min of sustained global normothermic ischemia, groups of hearts were treated with the PKC activators 4β-phorbol 12-myristate 13-acetate (PMA) or 1,2-dioctanoyl-sn-glycerol (DOG), a group of hearts was treated with the PKC inhibitor chelerythrine (CH), a group was treated with DOG plus CH, a group was preconditioned with four cycles of 5 min of ischemia and 5 min of reflow and a group was treated with CH during PC. Recovery of left ventricular developed pressure (% of initial, pretreatment, preischemic LVDP), measured after 20 min of reflow, was improved in hearts treated with DOG, but not PMA (80 ± 3% (DOG), 55 ± 3% (PMA) v 51 ± 3% (control), P <0.05 between DOG and control), although both caused a similar degree of PKC translocation (measured by fractionation followed by an assay of PKC activity using incorporation of 32P into histone). The improved recovery of LVDP in the PC group and in the DOG group was blocked by chelerythrine. Measurement of pH (by 31P NMR) showed that DOG reduced acidification at 15-20 min of ischemia, although the effect was not as great as PC, while PMA did not reduce acidification. The effect of DOG on pH, was attenuated by CH; however, the PC-induced attenuation of the fall in pH, was not affected by CH. High energy phosphates (measured by 31P NMR) were not significantly different between any of the groups during ischemia or renew, This study confirms that the protective effect of ischemic preconditioning on stunning in rat heart can be eliminated by inhibition of PKC, but suggests that the effect of PC on the fall in pH(i) duringsustained ischemia is not mediated by PKC.

Original languageEnglish (US)
Pages (from-to)871-880
Number of pages10
JournalJournal of Molecular and Cellular Cardiology
Volume28
Issue number5
DOIs
StatePublished - May 1996
Externally publishedYes

Fingerprint

Ischemic Preconditioning
Glycerol
Ischemia
Acetates
Ventricular Pressure
Histones
chelerythrine
Phosphates
phorbol-12-myristate

Keywords

  • 1,2-dioctanoyl-sn-glycerol
  • 4β-phorbol 12-myristate 13-acetate
  • Ischemia
  • Preconditioning
  • Protein kinase C
  • Reperfusion

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart. / Chen, Weina; Wetsel, William; Steenbergen, Charles Jr; Murphy, Elizabeth.

In: Journal of Molecular and Cellular Cardiology, Vol. 28, No. 5, 05.1996, p. 871-880.

Research output: Contribution to journalArticle

@article{f2b0e79ccbd74ade854930a60e3060dc,
title = "Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart",
abstract = "Ischemic preconditioning (PC) has been shown to attenuate intracellular acidification during a subsequent period of ischemia, to minimize stunning, and to decrease infarct size, PKC activation has been suggested to be involved in this phenomenon, The present study is designed to test whether PKC activation could mimic and PKC inhibition could block the PC effects on intracellular acidification during ischemia and on stunning during reflow in Langendorff perfused rat hearts. Prior to 20 min of sustained global normothermic ischemia, groups of hearts were treated with the PKC activators 4β-phorbol 12-myristate 13-acetate (PMA) or 1,2-dioctanoyl-sn-glycerol (DOG), a group of hearts was treated with the PKC inhibitor chelerythrine (CH), a group was treated with DOG plus CH, a group was preconditioned with four cycles of 5 min of ischemia and 5 min of reflow and a group was treated with CH during PC. Recovery of left ventricular developed pressure ({\%} of initial, pretreatment, preischemic LVDP), measured after 20 min of reflow, was improved in hearts treated with DOG, but not PMA (80 ± 3{\%} (DOG), 55 ± 3{\%} (PMA) v 51 ± 3{\%} (control), P <0.05 between DOG and control), although both caused a similar degree of PKC translocation (measured by fractionation followed by an assay of PKC activity using incorporation of 32P into histone). The improved recovery of LVDP in the PC group and in the DOG group was blocked by chelerythrine. Measurement of pH (by 31P NMR) showed that DOG reduced acidification at 15-20 min of ischemia, although the effect was not as great as PC, while PMA did not reduce acidification. The effect of DOG on pH, was attenuated by CH; however, the PC-induced attenuation of the fall in pH, was not affected by CH. High energy phosphates (measured by 31P NMR) were not significantly different between any of the groups during ischemia or renew, This study confirms that the protective effect of ischemic preconditioning on stunning in rat heart can be eliminated by inhibition of PKC, but suggests that the effect of PC on the fall in pH(i) duringsustained ischemia is not mediated by PKC.",
keywords = "1,2-dioctanoyl-sn-glycerol, 4β-phorbol 12-myristate 13-acetate, Ischemia, Preconditioning, Protein kinase C, Reperfusion",
author = "Weina Chen and William Wetsel and Steenbergen, {Charles Jr} and Elizabeth Murphy",
year = "1996",
month = "5",
doi = "10.1006/jmcc.1996.0082",
language = "English (US)",
volume = "28",
pages = "871--880",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart

AU - Chen, Weina

AU - Wetsel, William

AU - Steenbergen, Charles Jr

AU - Murphy, Elizabeth

PY - 1996/5

Y1 - 1996/5

N2 - Ischemic preconditioning (PC) has been shown to attenuate intracellular acidification during a subsequent period of ischemia, to minimize stunning, and to decrease infarct size, PKC activation has been suggested to be involved in this phenomenon, The present study is designed to test whether PKC activation could mimic and PKC inhibition could block the PC effects on intracellular acidification during ischemia and on stunning during reflow in Langendorff perfused rat hearts. Prior to 20 min of sustained global normothermic ischemia, groups of hearts were treated with the PKC activators 4β-phorbol 12-myristate 13-acetate (PMA) or 1,2-dioctanoyl-sn-glycerol (DOG), a group of hearts was treated with the PKC inhibitor chelerythrine (CH), a group was treated with DOG plus CH, a group was preconditioned with four cycles of 5 min of ischemia and 5 min of reflow and a group was treated with CH during PC. Recovery of left ventricular developed pressure (% of initial, pretreatment, preischemic LVDP), measured after 20 min of reflow, was improved in hearts treated with DOG, but not PMA (80 ± 3% (DOG), 55 ± 3% (PMA) v 51 ± 3% (control), P <0.05 between DOG and control), although both caused a similar degree of PKC translocation (measured by fractionation followed by an assay of PKC activity using incorporation of 32P into histone). The improved recovery of LVDP in the PC group and in the DOG group was blocked by chelerythrine. Measurement of pH (by 31P NMR) showed that DOG reduced acidification at 15-20 min of ischemia, although the effect was not as great as PC, while PMA did not reduce acidification. The effect of DOG on pH, was attenuated by CH; however, the PC-induced attenuation of the fall in pH, was not affected by CH. High energy phosphates (measured by 31P NMR) were not significantly different between any of the groups during ischemia or renew, This study confirms that the protective effect of ischemic preconditioning on stunning in rat heart can be eliminated by inhibition of PKC, but suggests that the effect of PC on the fall in pH(i) duringsustained ischemia is not mediated by PKC.

AB - Ischemic preconditioning (PC) has been shown to attenuate intracellular acidification during a subsequent period of ischemia, to minimize stunning, and to decrease infarct size, PKC activation has been suggested to be involved in this phenomenon, The present study is designed to test whether PKC activation could mimic and PKC inhibition could block the PC effects on intracellular acidification during ischemia and on stunning during reflow in Langendorff perfused rat hearts. Prior to 20 min of sustained global normothermic ischemia, groups of hearts were treated with the PKC activators 4β-phorbol 12-myristate 13-acetate (PMA) or 1,2-dioctanoyl-sn-glycerol (DOG), a group of hearts was treated with the PKC inhibitor chelerythrine (CH), a group was treated with DOG plus CH, a group was preconditioned with four cycles of 5 min of ischemia and 5 min of reflow and a group was treated with CH during PC. Recovery of left ventricular developed pressure (% of initial, pretreatment, preischemic LVDP), measured after 20 min of reflow, was improved in hearts treated with DOG, but not PMA (80 ± 3% (DOG), 55 ± 3% (PMA) v 51 ± 3% (control), P <0.05 between DOG and control), although both caused a similar degree of PKC translocation (measured by fractionation followed by an assay of PKC activity using incorporation of 32P into histone). The improved recovery of LVDP in the PC group and in the DOG group was blocked by chelerythrine. Measurement of pH (by 31P NMR) showed that DOG reduced acidification at 15-20 min of ischemia, although the effect was not as great as PC, while PMA did not reduce acidification. The effect of DOG on pH, was attenuated by CH; however, the PC-induced attenuation of the fall in pH, was not affected by CH. High energy phosphates (measured by 31P NMR) were not significantly different between any of the groups during ischemia or renew, This study confirms that the protective effect of ischemic preconditioning on stunning in rat heart can be eliminated by inhibition of PKC, but suggests that the effect of PC on the fall in pH(i) duringsustained ischemia is not mediated by PKC.

KW - 1,2-dioctanoyl-sn-glycerol

KW - 4β-phorbol 12-myristate 13-acetate

KW - Ischemia

KW - Preconditioning

KW - Protein kinase C

KW - Reperfusion

UR - http://www.scopus.com/inward/record.url?scp=0029996624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029996624&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1996.0082

DO - 10.1006/jmcc.1996.0082

M3 - Article

VL - 28

SP - 871

EP - 880

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 5

ER -